AU Patent

AU2002223680B2 — Synergistic combinations comprising a renin inhibitor for cardiovascular diseases

Assigned to Novartis AG · Expires 2005-04-07 · 21y expired

What this patent protects

A pharmaceutical composition comprising the renin inhibitor aliskiren or a pharmaceutically acceptable salt thereof and at least one therapeutic agent selected from the group consisting of a diuretic or a pharmaceutically acceptable salt thereof, and a carrier

USPTO Abstract

A pharmaceutical composition comprising the renin inhibitor aliskiren or a pharmaceutically acceptable salt thereof and at least one therapeutic agent selected from the group consisting of a diuretic or a pharmaceutically acceptable salt thereof, and a carrier

Drugs covered by this patent

Patent Metadata

Patent number: AU2002223680B2
Jurisdiction: AU
Classification: —
Expires: 2005-04-07
Drug substance claim: No
Drug product claim: No
Assignee: Novartis AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.